melanotan 2 pathways Benefits of Melanotan-II (MT-2) How Do Experimental Studies Characterize

The abovementioned example is potentially applicable to all human druggable proteins, that is, proteins that have been demonstrated to be able to bind a drug

doi:10.1111/bcp.12362

Since most of the proteins coded by mtDNA are involved in ETC, mutations and deletions in mtDNA would likely disturb ETC and increase ROS formation, creating a vicious cycle further inflicting mitochondrial damage [46]

Daily routine: Morning: Topical GHK-Cu to scalp Evening: Topical GHK-Cu to scalp Every day: BPC-157 500mcg subcutaneous injection 3x per week: TB-500 2-5mg subcutaneous injection (maintenance dose) Bedtime: IGF-1 LR3 50-60mcg (4-6 week cycles with breaks) Additional: Weekly microneedling with GHK-Cu application immediately after Monthly progress photos and measurements Expected results: This is the most aggressive protocol